EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Clinical Uses of Common Genetic Variants Associated with Common Diseases

David J Hunter, Michael Inouye

New England Journal of Medicine · 24.09.2026 · 395 (12) · 1206-1217

DOI: 10.1056/nejmra2413201 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift New England Journal of Medicine, erschienen am 24.09.2026. Verfasst von David J Hunter und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Genetic Risk Score, Genetic Variation, Pharmacogenetics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Twenty-five years after the draft of the human genome sequence, genomics has revolutionized many areas of biology, the diagnosis of familial and early-onset diseases, and the development of targeted therapies, particularly in oncology. Genomic knowledge has had little effect on the diagnosis and treatment of most common adult-onset conditions. Genomewide association studies have revealed that for these conditions, thousands of genetic variants of small effect underpin the polygenic nature of risk. When incorporated into polygenic risk scores, these variants predict risk; however, polygenic risk scores have had little effect in the clinic. In this article, we review the reasons for the slow pace of the diffusion of these methods in clinical practice. With the impending era of relatively inexpensive genome sequencing in mind, we review the ways in which polygenic risk scores, along with the related field of pharmacogenomics, may be useful in clinical practice for the prevention and treatment of common diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Risk ScoreGenetic VariationPharmacogeneticsHumansGenome-Wide Association StudyMolecular Targeted TherapyPrecision MedicineWhole Genome SequencingRisk Assessment

Autor:innen und Institutionen

  • Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston.
  • Broad Institute of MIT and Harvard, Cambridge, MA.
  • Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.

Zitieren

APA

Hunter, D. J., & Inouye, M. (2026). Clinical Uses of Common Genetic Variants Associated with Common Diseases. New England Journal of Medicine, 395(12), 1206-1217. https://doi.org/10.1056/nejmra2413201

Vancouver

Hunter DJ, Inouye M. Clinical Uses of Common Genetic Variants Associated with Common Diseases. New England Journal of Medicine. 2026;395(12):1206-1217. doi:10.1056/nejmra2413201

BibTeX
@article{Hunter2026,
  author = {Hunter, David J and Inouye, Michael},
  title = {Clinical Uses of Common Genetic Variants Associated with Common Diseases},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {395},
  number = {12},
  pages = {1206--1217},
  doi = {10.1056/nejmra2413201}
}
Kostenlos starten →